CN115551880A - 检测胰腺神经内分泌肿瘤 - Google Patents

检测胰腺神经内分泌肿瘤 Download PDF

Info

Publication number
CN115551880A
CN115551880A CN202180028122.XA CN202180028122A CN115551880A CN 115551880 A CN115551880 A CN 115551880A CN 202180028122 A CN202180028122 A CN 202180028122A CN 115551880 A CN115551880 A CN 115551880A
Authority
CN
China
Prior art keywords
methylation
sample
dna
bisulfite
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180028122.XA
Other languages
English (en)
Chinese (zh)
Inventor
大卫·A·阿尔奎斯特
约翰·B·基谢尔
威廉·R·泰勒
道格拉斯·W·马奥尼
舒纳克·麦金德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Clinic in Florida
Original Assignee
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Clinic in Florida filed Critical Mayo Clinic in Florida
Publication of CN115551880A publication Critical patent/CN115551880A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202180028122.XA 2020-05-04 2021-05-04 检测胰腺神经内分泌肿瘤 Pending CN115551880A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063019751P 2020-05-04 2020-05-04
US63/019,751 2020-05-04
PCT/US2021/030635 WO2021226071A2 (en) 2020-05-04 2021-05-04 Detecting pancreatic neuroendocrine tumors

Publications (1)

Publication Number Publication Date
CN115551880A true CN115551880A (zh) 2022-12-30

Family

ID=78468349

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180028122.XA Pending CN115551880A (zh) 2020-05-04 2021-05-04 检测胰腺神经内分泌肿瘤

Country Status (8)

Country Link
US (1) US20230167506A1 (https=)
EP (1) EP4146678A4 (https=)
JP (1) JP7830350B2 (https=)
KR (1) KR20230005845A (https=)
CN (1) CN115551880A (https=)
AU (1) AU2021268631A1 (https=)
CA (1) CA3172143A1 (https=)
WO (1) WO2021226071A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025194302A1 (zh) * 2024-03-18 2025-09-25 深圳华大基因股份有限公司 差异化甲基化区域组合及应用

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
CN120700143A (zh) 2014-03-31 2025-09-26 梅奥医学教育和研究基金会 检测结直肠赘生物
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
CN108350485A (zh) 2015-10-30 2018-07-31 精密科学发展有限责任公司 血浆dna的多重扩增检测测定以及分离和检测
CN109563546B (zh) 2016-05-05 2022-09-09 精密科学发展有限责任公司 通过分析甲基化dna来检测肺肿瘤
KR102892245B1 (ko) 2017-01-27 2025-11-27 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 메틸화된 dna 분석에 의한 결장 신조직형성의 검출
JP7277460B2 (ja) 2017-11-30 2023-05-19 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 乳癌の検出
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
CA3127329A1 (en) 2019-01-24 2020-07-30 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
US11702704B2 (en) 2019-10-31 2023-07-18 Mayo Foundation For Medical Education And Research Detecting ovarian cancer
EP4499859A1 (en) * 2022-03-31 2025-02-05 Illumina, Inc. Compositions including aqueous amine borane complexes and polynucleotides, and methods of using the same to detect methylcytosine or hydroxymethylcytosine
WO2026024692A1 (en) * 2024-07-24 2026-01-29 Guardant Health, Inc. Direct methylation single-base resolution sequencing of enriched unmethylated dna

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015156A1 (en) * 2003-03-17 2007-01-18 Goggins Michael G Aberrantly methylated genes in pancreatic cancer
WO2014160645A2 (en) * 2013-03-15 2014-10-02 Biotheranostics, Inc. Neuroendocrine tumors
US20180245163A1 (en) * 2017-02-28 2018-08-30 Mayo Foundation For Medical Education And Research Detecting prostate cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090077685A1 (en) * 1998-06-16 2009-03-19 Buehler Robert E Nucleic acid molecules and other molecules associated with plants
WO2002018631A2 (de) * 2000-09-01 2002-03-07 Epigenomics Ag Diagnose von bestehenden erkrankungen oder der prädisposition für bestimmte erkrankungen
WO2008073303A2 (en) * 2006-12-07 2008-06-19 Switchgear Genomics Transcriptional regulatory elements of biological pathways, tools, and methods
WO2012175562A2 (en) * 2011-06-21 2012-12-27 University Of Tartu Methylation and microrna markers of early-stage non-small cell lung cancer
AU2013275761B2 (en) * 2012-06-14 2017-09-28 Aarhus Universitet Biomarkers for prostate cancer
US20180051343A1 (en) * 2014-08-08 2018-02-22 Ait Austrian Institute Of Technology Gmbh Thyroid cancer diagnosis by dna methylation analysis
US10370726B2 (en) * 2016-04-14 2019-08-06 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasia
JP7481804B2 (ja) * 2016-04-14 2024-05-13 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 高度膵異形成の検出
WO2019010429A1 (en) * 2017-07-07 2019-01-10 The Trustees Of The University Of Pennsylvania METHODS OF DIAGNOSING PANCREATIC CANCER
US10648025B2 (en) * 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015156A1 (en) * 2003-03-17 2007-01-18 Goggins Michael G Aberrantly methylated genes in pancreatic cancer
WO2014160645A2 (en) * 2013-03-15 2014-10-02 Biotheranostics, Inc. Neuroendocrine tumors
US20180245163A1 (en) * 2017-02-28 2018-08-30 Mayo Foundation For Medical Education And Research Detecting prostate cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SHOUNAK MAJUMDER等: "Molecular detection of pancreatic neuroendocrine tumors using methylated DNA markers: Discovery and tissue validation.", JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 25 May 2020 (2020-05-25), pages 1 - 2 *
YINGYING ZHANG等: "DNA Methylation Analysis of Chromosome 21 Gene Promoters at Single Base Pair and Single Allele Resolution", PLOS GENETICS,, vol. 5, no. 5, 17 March 2009 (2009-03-17), pages 1 - 15 *
张统雨;樊红樱;朱才业;刘家鑫;邓天宇;杜立新;王立贤;赵福平;: "利用可变窗口F_(ST)方法检测不同尾型呼伦贝尔羊尾部脂肪沉积相关基因", 畜牧兽医学报, no. 07, 15 July 2018 (2018-07-15), pages 34 - 45 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025194302A1 (zh) * 2024-03-18 2025-09-25 深圳华大基因股份有限公司 差异化甲基化区域组合及应用

Also Published As

Publication number Publication date
AU2021268631A1 (en) 2023-01-05
US20230167506A1 (en) 2023-06-01
WO2021226071A3 (en) 2021-12-09
EP4146678A4 (en) 2025-08-27
WO2021226071A2 (en) 2021-11-11
JP7830350B2 (ja) 2026-03-16
CA3172143A1 (en) 2021-11-11
EP4146678A2 (en) 2023-03-15
KR20230005845A (ko) 2023-01-10
JP2023524740A (ja) 2023-06-13

Similar Documents

Publication Publication Date Title
JP7757338B2 (ja) 乳癌の検出
JP7830350B2 (ja) 膵神経内分泌腫瘍の検出
JP7799607B2 (ja) 卵巣癌の検出
US11697853B2 (en) Detecting prostate cancer
US12584177B2 (en) Detecting endometrial cancer
JP7680365B2 (ja) 血漿中の膵管腺癌の検出
US20230357852A1 (en) Detecting non-hodgkin lymphoma
JP7293109B2 (ja) 肝細胞癌の検出
JP2025029006A (ja) メラノーマの検出

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination